Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.
@article{Jyonouchi2017PhaseIT, title={Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.}, author={S. Jyonouchi and Brenda Gwafila and L. A. Gwalani and Maria Ahmad and Chistopher Moertel and Cecil Holbert and J. Kim and N. Kobrinsky and S. Roy-Ghanta and J. Orange}, journal={Clinical immunology}, year={2017}, volume={179}, pages={ 47-53 } }
BACKGROUND
Low dose IL-2 can restore the function of T and NK cells from Wiskott-Aldrich (WAS) patients. However, the safety of in vivo IL-2 in WAS is unknown.
OBJECTIVES
A phase-I study to assess safety of low dose IL-2 in WAS.
METHODS
Patients received 5 daily subcutaneous IL-2 injections, every 2months, for three courses. A "3+3" dose escalation method was used.
RESULTS
6 patients received the 0.5millionunits/m2/day dose without serious adverse events. However, 2 of 3 patients… CONTINUE READING
Topics from this paper
15 Citations
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
- Medicine
- Wellcome open research
- 2020
- 3
Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways
- Medicine
- Theranostics
- 2020
- 6
- Highly Influenced
- PDF
HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice
- Frontiers in Immunology
- 2021
Low Dose Medicine: theoretical background and scientific evidence
- Medicine
- Italian Journal of Pediatrics
- 2018
- 2
Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome
- Medicine
- Journal of Clinical Immunology
- 2017
- 58
Wiskott-Aldrich syndrome in four male siblings from a consanguineous family from Lebanon.
- Medicine
- Clinical immunology
- 2020
Primary Immunodeficiency Diseases: Current and Emerging Therapeutics
- Biology, Medicine
- Front. Immunol.
- 2017
- 24
- PDF
Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse
- Medicine
- Frontiers in Immunology
- 2020
- PDF
Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease
- Medicine
- Frontiers in Immunology
- 2020
References
SHOWING 1-10 OF 28 REFERENCES
Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata.
- Medicine
- JAMA dermatology
- 2014
- 138
- PDF
Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion.
- Medicine
- The American journal of medicine
- 1990
- 42
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
- Medicine
- The New England journal of medicine
- 2011
- 564
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.
- Medicine
- The lancet. Diabetes & endocrinology
- 2013
- 235
Interleukin-2 and regulatory T cells in graft-versus-host disease.
- Medicine
- The New England journal of medicine
- 2011
- 794
- PDF
An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome.
- Medicine
- Clinical immunology
- 2003
- 52
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
- Medicine
- The Journal of infectious diseases
- 2002
- 63
- PDF
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.
- Medicine
- Blood
- 2010
- 147
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- Medicine
- Annals of the rheumatic diseases
- 2016
- 170
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene
- Medicine
- Journal of Clinical Immunology
- 2014
- 16